115 related articles for article (PubMed ID: 371818)
1. Inhibitory and stimulatory effects of a synthetic glycopeptide (MDP) on the in vitro PFC response: factors affecting the response.
Leclerc C; Juy D; Chedid L
Cell Immunol; 1979 Feb; 42(2):336-43. PubMed ID: 371818
[No Abstract] [Full Text] [Related]
2. Opposite effects of the synthetic adjuvant N-acetyl-muramyl-L-alanyl-D-isoglutamine on the immune response in mice depending on experimental conditions.
Souvannavong V; Adam A
Eur J Immunol; 1980 Aug; 10(8):654-6. PubMed ID: 6995138
[TBL] [Abstract][Full Text] [Related]
3. Influence of a synthetic adjuvant (MDP) on qualitative and quantitative changes of serum globulins.
Leclerc C; Audibert F; Chedid L
Immunology; 1978 Dec; 35(6):963-70. PubMed ID: 738768
[TBL] [Abstract][Full Text] [Related]
4. Induction of antibodies directed against self and altered-self determinants by a synthetic adjuvant, muramyl dipeptide and some of its derivatives.
Löwy I; Leclerc C; Chedid L
Immunology; 1980 Mar; 39(3):441-50. PubMed ID: 6160092
[TBL] [Abstract][Full Text] [Related]
5. Immunoadjuvant effects of the synthetic muramyl-dipeptide (MDP) N-acetylmuramyl-L-alanyl-D-isoglutamine.
Heymer B; Finger H; Wirsing CH
Z Immunitatsforsch Immunobiol; 1978 Oct; 155(1):87-92. PubMed ID: 706536
[TBL] [Abstract][Full Text] [Related]
6. Efficient genetically controlled formation of antibody to a synthetic antigen [poly(LTyr, LGlu)-poly(DLAla)- -poly(LLys)] covalently bound to a synthetic adjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine).
Mozes E; Sela M; Chedid L
Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4933-7. PubMed ID: 6776530
[TBL] [Abstract][Full Text] [Related]
7. The macrophage, target cell of the synthetic adjuvant muramyl dipeptide.
Fevrier M; Birrien JL; Leclerc C; Chedid L; Liacopoulos P
Eur J Immunol; 1978 Aug; 8(8):558-62. PubMed ID: 359336
[TBL] [Abstract][Full Text] [Related]
8. Past, present and future of the synthetic immunoadjuvant MDP and its analogs.
Chedid L; Lederer E
Biochem Pharmacol; 1978; 27(18):2183-6. PubMed ID: 365182
[No Abstract] [Full Text] [Related]
9. Biological studies of lipophilic MDP-derivatives incorporated in liposomes.
Jolivet M; Sache E; Audibert F
Immunol Commun; 1981; 10(6):511-22. PubMed ID: 7319546
[TBL] [Abstract][Full Text] [Related]
10. Modulation of the immunosuppressive activity of CKS-17, a synthetic retroviral envelope peptide, by muramyl dipeptide.
Gauduin MC; Vogel FR; Simon JP; Audibert FA; Chedid LA
Viral Immunol; 1993; 6(3):175-83. PubMed ID: 8292225
[TBL] [Abstract][Full Text] [Related]
11. Biological activities of muramyl dipeptide, a synthetic glycopeptide analogous to bacterial immunoregulating agents.
Chedid L; Audibert F; Johnson AG
Prog Allergy; 1978; 25():63-105. PubMed ID: 362430
[No Abstract] [Full Text] [Related]
12. Synthesis of conjugates containing N-acetylmuramyl-L-alanyl-D-isoglutaminyl (MDP). Their use as hapten-carrier systems.
Reichert CM; Carelli C; Jolivet M; Audibert F; Lefrancier P; Chedid L
Mol Immunol; 1980 Mar; 17(3):357-63. PubMed ID: 7442679
[No Abstract] [Full Text] [Related]
13. In vitro spleen cell responsiveness to various analogs of MDP (N-acetylmuramyl-L-alanyl-D-isoglutamine), a synthetic immunoadjuvant, in MDP high-responder mice.
Damais C; Parant M; Chedid L; Lefrancier P; Choay J
Cell Immunol; 1978 Jan; 35(1):173-9. PubMed ID: 563773
[No Abstract] [Full Text] [Related]
14. [Biological properties of synthetic glycopeptides stimulating immunogenesis and nonspecific resistance].
Dzheksenbaev OSh
Zh Mikrobiol Epidemiol Immunobiol; 1981; (8):13-8. PubMed ID: 7032159
[No Abstract] [Full Text] [Related]
15. Effect of concanavalin A in vivo in suppressing the antibody response in mice.
Egan HS; Reeder WJ; Ekstedt RD
J Immunol; 1974 Jan; 112(1):63-9. PubMed ID: 4590828
[No Abstract] [Full Text] [Related]
16. Recent developments concerning muramyl dipeptide, a synthetic immunoregulating molecule.
Chedid L; Carelli C; Audibert F
J Reticuloendothel Soc; 1979 Dec; 26(Suppl):631-41. PubMed ID: 392087
[No Abstract] [Full Text] [Related]
17. Cellular requirements for the primary in vitro antibody response to DNP-ficoll.
Mosier DE; Johnson BM; Paul WE; McMaster PR
J Exp Med; 1974 May; 139(5):1354-60. PubMed ID: 4596514
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of mitogen-induced polyclonal activation by by a synthetic adjuvant, muramyl dipeptide (MDP).
Löwy I; Leclerc C; Bourgeois E; Chedid L
J Immunol; 1980 Jan; 124(1):320-5. PubMed ID: 6985643
[TBL] [Abstract][Full Text] [Related]
19. Effect of antigenic competition on antigen-sensitive cells and on adoptively transferred immunocompetent cells.
Möller G; Sjöberg O
Cell Immunol; 1970 May; 1(1):110-21. PubMed ID: 4943425
[No Abstract] [Full Text] [Related]
20. Further study on relationship of anti-tuberculous protection to lung granulomata produced by intravenous injections of synthetic 6-0-mycoloyl-N-acetyl-muramyl-L-alanyl-D-isoglutamine with or without specific antigens.
Yamamoto K; Kato K; Kakinuma M; Okuyama H; Azuma I
Immunology; 1982 Jun; 46(2):473-9. PubMed ID: 7044961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
